Senate Democrats on Tuesday are unveiling a proposal to expand Medicare drug price negotiations, in a bid to counter President Trump's election-year messaging on health care affordability. Why it matters: High prescription drug prices are a key concern for voters ahead of the midterms — one Trump is trying to address through voluntary pricing deals with leading drug companies and with the TrumpRx website.